Rossell Biotech Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 3.26 Cr
as on 26-06-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 201.78%
(FY 2022)
- Profit 229.61%
(FY 2022)
- Ebitda -659.21%
(FY 2022)
- Net Worth 7.76%
(FY 2022)
- Total Assets 66.02%
(FY 2022)
About Rossell Biotech
The Corporate was formerly known as Ykm Bio-Tech Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 3.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kushal Aggarwal, Swati Aggarwal, and Ankit Aggarwal serve as directors at the Company.
- CIN/LLPIN
U02001DL1996PLC075229
- Company No.
075229
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rossell Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Aggarwal  | Director | 30-Sep-2016 | Current |
| Kushal Aggarwal | Director | 30-Sep-2016 | Current |
| Swati Aggarwal | Director | 30-Sep-2016 | Current |
Financial Performance of Rossell Biotech.
Rossell Biotech Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 201.78% increase. The company also saw a substantial improvement in profitability, with a 229.61% increase in profit. The company's net worth moved up by a moderate rise of 7.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rossell Biotech?
In 2018, Rossell Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivalik Prints LimitedActive 26 years 4 monthsKushal Aggarwal and Ankit Aggarwal are mutual person
- Shivalik Urban Landscapes Private LimitedActive 13 years 10 months
Ankit Aggarwal is a mutual person
- Narendra Infra Buildtech LlpActive 1 year 1 month
Kushal Aggarwal and Ankit Aggarwal are mutual person
- Tauru Logistics & Warehousing Park Private LimitedActive 3 years 7 months
Kushal Aggarwal and Ankit Aggarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rossell Biotech?
Unlock and access historical data on people associated with Rossell Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rossell Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rossell Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
